News

Duke Institute for Health Innovation (DIHI), along with other sponsors from Duke University Main Campus, Duke Health, and PDC, is organizing the third Innovation Jam. This will be a shark tank-style event on October 3, 2017, where Duke innovators, inventors and entrepreneurs will have an opportunity to pitch their ideas to a team of internal “investors.” All faculty, staff, trainees and students are encouraged to apply.

Registration is now open for the next School of Medicine Financial Boot Camp, a multi-part series designed to help faculty understand core finance issues with a focus on medical school economics.

The School of Medicine will host a workshop on time management for researchers led by Peter Ubel, MD, from 12-1:30 p.m. on Mon., Aug. 7.

Courtney Van Houtven, PhD, shares some of her research she is doing as Director of the VA Caregiver Support Program Evaluation. 

Bradley Hammill, DrPH, joined the Duke Division of General Internal Medicine in March of 2016. He is a Senior Biostatistician with the Duke Clinical Research Institute (DCRI) and was recently named Associate Professor of Medicine. Learn more about him in our interview below:

Catch up with the Duke Internal Medicine Residency Program by reading the weekly newsletter for June 19, 2017.

Jennifer Rymer, MD, MBA, cardiovascular disease fellow, will receive The Mario Family Foundation Award, which supports junior investigators in training in the Department of Medicine to make the transition to become independent scientists and planning for their first extra-mural funding.

Another academic year is coming to end, which means it's time to recognize individuals who have exemplified excellence in teaching during the year.  Three teaching awards were given out and we are proud to announce the recipients are all GIM faculty members! 

On June 12, Forbes Pharma & Healthcare published an op-ed by DGIM's Dr. Hayden Bosworth entitled, "Why Medication Adherence Needs To Be A National Priority".

DGIM's own Leah Zullig, PhD, was featured on the cover for a recent paper she wrote on the need for inclusion of minorities and other traditionally underrepresented groups in cancer clinical trials.